A non-government resource for the Medicare community
Powered by Q1Group LLC
A non-government Medicare community resource
  • Menu
  • Home
  • Contact
  • MAPD
  • PDP
  • 2024
  • 2025
  • FAQs
  • Articles
  • Search
  • Contact
  • 2024
  • 2025
  • FAQs
  • Articles
  • Latest Medicare News
  • Search

April 2018 formulary changes: 2018 Medicare Part D drug lists now updated with 486 new prescription drugs - Part 5 of 5 - Drugs starting with the letters Q-Z.

Category: Monthly Formulary changes
Published: Apr, 24 2018 05:04:09


The April, 2018 Medicare Part D plan formulary data (or drug list updates) includes the addition of 737 new National Drug Codes (NDCs) to the Medicare Part D program.  These NDCs represent 486 different drugs, many with multiple strengths. There are so many new NDCs, that we have to split the list into 5 parts. This article will cover Medicare Part D drugs starting with the letters Q through Z. Here are links to A-C, D-H, I-M, and N-P.

Fifty-seven new NDC generic equivalents were added, including RILUZOLE [Rilutek®], RIZATRIPTAN [Maxalt-MLT®], ROSUVASTATIN CALCIUM [Crestor®], SCOPOLAMINE [Transderm Scop®], SEVELAMER [RENVELA®], SULFAMETHOXAZOLE-TMP [Bactrim®], TAZAROTENE [Tazorac®], TELMISARTAN-HCTZ [Micardis HCT®], TOBRAMYCIN [Bethkis, Tobi, Tobi Podhaler, Tobramycin Sulfate®]; VIGABATRIN [SABRIL®], ZOLEDRONIC ACID [Zometa®], and ZOLMITRIPTAN [Zomig®], amongst others.  See details in the chart below.

What exactly is an NDC?
As a reminder, the NDC uniquely identifies a particular manufacturer, drug-strength, and packaging combination. The NDC for your medication is often shown on your prescription bottle as an 11-digit code (see the charts below) or could be formatted as 00000-0000-00 where the first set of numbers identifies the manufacturer, the second set of number identifies the drug and strength, and the third set of numbers identifies the packaging.

Why is there a new NDC?
New NDCs can be added to the Medicare Part D program for a number of reasons including any combination of new manufacturer, drug-strength, delivery form, or packaging. Usually we provide for each NDCs the reason for the NDC addition. With 737 new NDCs, determining the reason was time prohibitive.

More about the newly added NDCs ...
The following chart details the 737 new manufacturer / drug-strength / packaging combinations (NDCs) that were added to one or more Medicare Part D formularies in the most recent updates. You can click on the Drug Code (NDC) below to go to our Q1Medicare.com Drug Finder (Q1Rx.com) to see the details of how this drug is covered by all Medicare Part D Plans in Florida -- You can then change the state to your state for details in your service area.

NDC Drug Name
00310678030 QTERN 10 MG-5 MG TABLET
69097084305 QUINAPRIL 40 MG TABLET
68180055609 QUINAPRIL 5 MG TABLET
69097082805 QUINAPRIL-HCTZ 10-12.5 MG TAB
69097082905 QUINAPRIL-HCTZ 20-12.5 MG TAB
69097083105 QUINAPRIL-HCTZ 20-25 MG TAB
70510217102 RADICAVA 30 MG/100 ML BAG
68382014406 RAMIPRIL 1.25 MG CAPSULE
55111012905 RANITIDINE 150 MG CAPSULE
68462024805 RANITIDINE 150 MG TABLET
70301100101 RAYALDEE ER 30 MCG CAPSULE
00006430502 RENFLEXIS 100 MG VIAL FOR INJECTION
00023916360 RESTASIS 0.05% EYE EMULSION
00187517015 RETIN-A 0.025% GEL
00187514650 RETIN-A MICRO PUMP 0.06% GEL
70515070060 RILUTEK 50 MG TABLET
68462038160 RILUZOLE 50 MG TABLET [Rilutek]
50458031528 RISPERDAL 1MG M-TAB
00378350291 RISPERIDONE 0.25 MG TABLET
50242005121 RITUXAN 10 MG/ML VIAL
33342009372 RIZATRIPTAN 5 MG ODT [Maxalt-MLT]
33342008750 RIZATRIPTAN 5 MG TABLET [Maxalt-MLT]
31722088390 ROSUVASTATIN CALCIUM 10 MG TAB [Crestor]
60505450409 ROSUVASTATIN CALCIUM 20 MG TAB [Crestor]
60505450503 Rosuvastatin Calcium 40 mg Film Coated Tablet [Crestor]
31722088290 ROSUVASTATIN CALCIUM 5 MG TAB [Crestor]
00037006605 Rowasa Rectal 4 G 60 ml Kit 28X60
00078069899 RYDAPT 25 MG CAPSULE
50484001030 SANTYL OINTMENT
45802058084 SCOPOLAMINE 1 MG/3 DAY PATCH [Transderm Scop]
65862093090 SEVELAMER 0.8 GM POWDER PACKET [RENVELA]
65862093190 Sevelamer Carbonate 40 MG/ML Oral Suspension [RENVELA]
65862092127 SEVELAMER CARBONATE 800 MG TAB [RENVELA]
68180046509 SIMVASTATIN 80 MG TABLET
00338004804 SODIUM CHLORIDE 0.9% IRRIG.
00338055318 SODIUM CHLORIDE 0.9% SOLUTION
10702003645 SODIUM POLYSTYRENE SULF POWDER
00009001820 Solu-Medrol, Preservative Free 1000 MG / 8 ML Vial
00299382345 SOOLANTRA 1% CREAM
51862037660 SORILUX 0.005% FOAM
24338053025 SOTYLIZE 5 MG/ML ORAL SOLUTION
59746021801 SPIRONOLACTONE 100 MG TABLET
53746051101 SPIRONOLACTONE 25 MG TABLET
59746021701 SPIRONOLACTONE 50 MG TABLET
53489014401 SPIRONOLACTONE-HCTZ 25-25 TAB
57894006002 STELARA 45 MG/0.5 ML VIAL
00338000404 STERILE WATER FOR IRRIGATION
70515050010 SULAR ER 8.5 MG TABLET
65862042005 SULFAMETHOXAZOLE-TMP DS TABLET [Bactrim]
00591079601 SULFASALAZINE 500 MG TABLET
42806001801 SULINDAC 150 MG TABLET
00781317207 SUMATRIPTAN 6 MG/0.5 ML INJECT
27437020702 SUPRAX 500 MG/5 ML SUSPENSION
59011052390 SYMPROIC 0.2 MG TABLET
20482033530 SYNDROS 5 MG/ML SOLUTION
50222022781 TACLONEX OINTMENT
57237001405 TAMSULOSIN HCL 0.4 MG CAPSULE
51672137302 TAZAROTENE 0.1% CREAM [Tazorac]
62037069730 TAZTIA XT 180 MG CAPSULE
62037069930 TAZTIA XT 300 MG CAPSULE
62332021030 TELMISARTAN-HCTZ 80-12.5 MG TAB [Micardis HCT]
62332021130 TELMISARTAN-HCTZ 80-25 MG TAB [Micardis HCT]
67877014930 TEMAZEPAM 22.5 MG CAPSULE
69097085902 TERBINAFINE HCL 250 MG TABLET
45802061001 TESTOSTERONE 30 MG/1.5 ML PUMP
60505100501 TIMOLOL 0.5% EYE DROPS
61314022505 TIMOLOL 0.5% GFS GEL-SOLUTION
65162091446 TOBRAMYCIN 300 MG/5 ML AMPULE [Bethkis, Tobi, Tobi Podhaler, Tobramycin Sulfate]
64370042140 TOLAK 4% CREAM
69097012403 TOPIRAMATE 100 MG TABLET
69097012203 TOPIRAMATE 25 MG TABLET
50111091801 TORSEMIDE 100 MG TABLET
66215010314 TRACLEER 32 MG TABLET FOR SUSP
10370022111 TRAMADOL ER 100 MG TABLET
10370022211 TRAMADOL ER 200 MG TABLET
47335053788 TRAMADOL ER 300 MG TABLET
68382031910 TRAMADOL HCL 50 MG TABLET
23155016641 TRANEXAMIC ACID 1,000 MG/10 ML
66758020854 TRANSDERM-SCOP 1.5 MG/3 DAY
55292030401 TRANXENE T-TAB 7.5 MG
00338064406 TRAVASOL 10% SOLUTION VIAFLEX
63459039008 TREANDA 25 MG VIAL
00173088710 TRELEGY ELLIPTA 100-62.5-25
57894064001 TREMFYA 100 MG/ML SYRINGE
00574232515 TRETINOIN 0.025% GEL
52565001059 TRIAMCINOLONE 0.025% LOTION
00168000415 TRIAMCINOLONE 0.1% CREAM
00168000615 TRIAMCINOLONE 0.1% OINTMENT
64980032005 TRIAMCINOLONE 0.1% PASTE
60505265605 TRIAMTERENE-HCTZ 37.5-25 MG TB
59762371809 TRIAZOLAM 0.25 MG TABLET
00781103001 TRIFLUOPERAZINE 1MG TABLET
16571016110 TRIHEXYPHENIDYL 5 MG TABLET
43386066003 TRIMETHOBENZAMIDE 300 MG CAP
43386033001 TRIMETHOPRIM 100 MG TABLET
51991094601 TRIMIPRAMINE MALEATE 100 MG CP
51991094401 TRIMIPRAMINE MALEATE 25 MG CAP
51991094501 TRIMIPRAMINE MALEATE 50 MG CAP
63459060106 TRISENOX 12 MG/6 ML VIAL
17772010401 TROKENDI XR 200 MG CAPSULE
17772010101 TROKENDI XR 25 MG CAPSULE
17772010230 TROKENDI XR 50 MG CAPSULE
58160081552 TWINRIX VACCINE SYRINGE
70539000102 TYMLOS 80 MCG DOSE PEN INJECTR
65293000901 VABOMERE 2 GRAM VIAL
31722070430 VALACYCLOVIR HCL 500 MG TABLET
69452015020 VALPROIC ACID 250 MG CAPSULE
00603184158 Valproic Acid 250mg/5mL 473 mL in 1 BOTTLE
00006484100 Vaqta Hepatitis A Vaccine Adult 50 Unit / mL Injection Single Dose Vial 1 mL
00006483141 Vaqta Hepatitis A Vaccine Pediatric / Adolescent 25 Unit / 0.5 mL Injection Single Dose Vial 0.5 mL
29033004530 VENLAFAXINE HCL ER 150 MG TAB
13811071230 VENLAFAXINE HCL ER 37.5 MG TAB
13811071330 VENLAFAXINE HCL ER 75 MG TAB
00002481554 VERZENIO 100 MG TABLET
00002533754 VERZENIO 150 MG TABLET
00002621654 VERZENIO 200 MG TABLET
00002448354 VERZENIO 50 MG TABLET
00087663341 VIDEX 4 GM PEDIATRIC SOLN
49884035852 VIGABATRIN 500 MG POWDER PACKET [SABRIL]
25021020405 VINORELBINE 50 MG/5 ML VIAL
00078034342 VIVELLE-DOT 0.0375MG PATCH 8 POUCH CRTN (1 X 8 POUCH CRTN)
00078034442 VIVELLE-DOT 0.05MG PATCH 8 POUCH CRTN (1X8 POUCH CRTN)
00078034642 VIVELLE-DOT 0.1 MG PATCH
61958240101 VOSEVI 400-100-100 MG TABLET
68727074501 VYXEOS 44 MG-100 MG VIAL
24208050405 VYZULTA 0.024% OPHTH SOLUTION
00093172001 WARFARIN SODIUM 10 MG TABLET
52652200101 XATMEP 2.5 MG/ML ORAL SOLUTION
10631033230 XIMINO ER 135 MG CAPSULE
10631033030 XIMINO ER 45 MG CAPSULE
10631033130 XIMINO ER 90 MG CAPSULE
00169291115 XULTOPHY 100 UNIT-3.6MG/ML PEN
69468015202 XURIDEN GRANULE PACKET
51862003603 ZARAH TABLET
00023611201 ZENPEP DR 20,000 UNIT CAPSULE
00078067919 ZOFRAN ODT 4 MG TABLET
00078068019 ZOFRAN ODT 8 MG TABLET
60505611000 ZOLEDRONIC ACID 4 MG/5 ML VIAL [Zometa]
68382071782 ZOLMITRIPTAN 5 MG ODT [Zomig, Zomig-ZMT]
69097086107 ZONISAMIDE 100 MG CAPSULE
70785001130 ZURAMPIC 200 MG TABLET
99207027175 ZYCLARA 3.75% CREAM PUMP
00009513802 ZYVOX 600 MG TABLET

This article will covered drugs starting with the letters Q through Z. Here are links to A-C, D-H, I-M, and N-P.

Looking for a way to review any Medicare Part D plan formulary?
You can review any Medicare plan formulary using the Q1Medicare.com FormularyBrowser at FormularyBrowser.com or compare how any medication is covered on all Medicare plans in your service area using our Q1Rx.com.
*Please remember that a Medicare prescription drug plan can change their plan's formulary at any time throughout the year (adding or dropping drugs) and you can telephone your Medicare plan's Member Services department to learn about the most recent formulary changes - the toll-free number for Member Services is found on your Member ID card.






Medicare Supplements
fill the gaps in your
Original Medicare
1. Enter Your ZIP Code:
» Medicare Supplement FAQs




Check Your Savings Using a Drug Discount Card
Prescription Discounts are
easy as 1-2-3
  1. Locate lowest price drug and pharmacy
  2. Show card at pharmacy
  3. Get instant savings!
Your drug discount card is available to you at no cost.




Tips & Disclaimers
  • Q1Medicare®, Q1Rx®, and Q1Group® are registered Service Marks of Q1Group LLC and may not be used in any advertising, publicity, or for commercial purposes without the express authorization of Q1Group.
  • The Medicare Advantage and Medicare Part D prescription drug plan data on our site comes directly from Medicare and is subject to change.
  • Medicare has neither reviewed nor endorsed the information on our site.
  • We provide our Q1Medicare.com site for educational purposes and strive to present unbiased and accurate information. However, Q1Medicare is not intended as a substitute for your lawyer, doctor, healthcare provider, financial advisor, or pharmacist. For more information on your Medicare coverage, please be sure to seek legal, medical, pharmaceutical, or financial advice from a licensed professional or telephone Medicare at 1-800-633-4227.
  • We are an independent education, research, and technology company. We are not affiliated with any Medicare plan, plan carrier, healthcare provider, or insurance company. We are not compensated for Medicare plan enrollments. We do not sell leads or share your personal information.
  • Benefits, formulary, pharmacy network, provider network, premium and/or co-payments/co-insurance may change on January 1 of each year. Our PDPCompare.com and MACompare.com provide highlights of annual plan benefit changes.
  • The benefit information provided is a brief summary, not a complete description of benefits. For more information contact the plan.
  • Limitations, copayments, and restrictions may apply.
  • We make every effort to show all available Medicare Part D or Medicare Advantage plans in your service area. However, since our data is provided by Medicare, it is possible that this may not be a complete listing of plans available in your service area. For a complete listing please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
    Statement required by Medicare:
    "We do not offer every plan available in your area. Any information we provide is limited to those plans we do offer in your area. Please contact Medicare.gov or 1-800-MEDICARE to get information on all of your options."
  • When enrolling in a Medicare Advantage plan, you must continue to pay your Medicare Part B premium.
  • Medicare beneficiaries with higher incomes may be required to pay both a Medicare Part B and Medicare Part D Income Related Monthly Adjustment Amount (IRMAA). Read more on IRMAA.
  • Medicare Advantage plans that include prescription drug coverage (MAPDs) are considered Medicare Part D plans and members with higher incomes may be subject to the Medicare Part D Income Related Monthly Adjustment Amount (IRMAA), just as members in stand-alone Part D plans. In certain situations, you can appeal IRMAA.
  • You must be enrolled in both Medicare Part A and Part B to enroll in a Medicare Advantage plan. Members may enroll in a Medicare Advantage plan only during specific times of the year. Contact the Medicare plan for more information.
  • If you are enrolled in a Medicare plan with Part D prescription drug coverage, you may be eligible for financial Extra Help to assist with the payment of your prescription drug premiums and drug purchases. To see if you qualify for Extra Help, call: 1-800-MEDICARE (1-800-633-4227). TTY users should call 1-877-486-2048, 24 hours a day/ 7 days a week or consult www.medicare.gov; the Social Security Office at 1-800-772-1213 between 7 a.m. and 7 p.m., Monday through Friday. TTY users should call, 1-800-325-0778; or your state Medicaid Office.
  • Medicare evaluates plans based on a 5-Star rating system. Star Ratings are calculated each year and may change from one year to the next.
  • A Medicare Advantage Private Fee-for-Service plan (PFFS) is not a Medicare supplement plan. Providers who do not contract with the plan are not required to see you except in an emergency.
  • Disclaimer for Institutional Special Needs Plan (SNP): This plan is available to anyone with Medicare who meets the Skilled Nursing Facility (SNF) level of care and resides in a nursing home.
  • Disclaimer for Dual Eligible (Medicare/Medicaid) Special Needs Plan (SNP): This plan is available to anyone who has both Medical Assistance from the State and Medicare. Premiums, co-pays, co-insurance, and deductibles may vary based on the level of Extra Help you receive. Please contact the plan for further details.
  • Disclaimer for Chronic Condition Special Needs Plan (SNP): This plan is available to anyone with Medicare who has been diagnosed with the plan specific Chronic Condition.
  • Medicare MSA Plans combine a high deductible Medicare Advantage Plan and a trust or custodial savings account (as defined and/or approved by the IRS). The plan deposits money from Medicare into the account. You can use this money to pay for your health care costs, but only Medicare-covered expenses count toward your deductible. The amount deposited is usually less than your deductible amount, so you generally have to pay out-of-pocket before your coverage begins.
  • Medicare MSA Plans do not cover prescription drugs. If you join a Medicare MSA Plan, you can also join any separate (stand-alone) Medicare Part D prescription drug plan
  • There are additional restrictions to join an MSA plan, and enrollment is generally for a full calendar year unless you meet certain exceptions. Those who disenroll during the calendar year will owe a portion of the account deposit back to the plan. Contact the plan provider for additional information.
  • Medicare beneficiaries may enroll through the CMS Medicare Online Enrollment Center located at www.medicare.gov.
  • Medicare beneficiaries can file a complaint with the Centers for Medicare & Medicaid Services by calling 1-800-MEDICARE 24 hours a day/7 days or using the medicare.gov site. Beneficiaries can appoint a representative by submitting CMS Form-1696.